Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy
Identifieur interne : 003092 ( Istex/Corpus ); précédent : 003091; suivant : 003093Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy
Auteurs : Kenta Sato ; Ryuji Kaji ; Sadayuki Matsumoto ; Satoshi GotoSource :
- Movement Disorders [ 0885-3185 ] ; 2007-04-15.
English descriptors
- KwdEn :
Abstract
Using antibodies to calcineurin (CaN) and choline acetyltransferase (ChAT), we performed topographical and cellular immunohistochemical analysis on the posterior putamen of autopsied patients with multiple system atrophy with predominant parkinsonism (MSA‐P). We document that in these patients, medium spiny neurons positive for CaN were severely depleted in the dorsolateral portion of the posterior putamen where ChAT‐positive neurons are normally distributed. Our findings indicate that in patients with MSA‐P, striatal neurons manifest a cell type‐specific vulnerability to neurodegeneration. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21385
Links to Exploration step
ISTEX:82D7E5D647067812CD396FB00B3790D3EAA69E24Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title><author><name sortKey="Sato, Kenta" sort="Sato, Kenta" uniqKey="Sato K" first="Kenta" last="Sato">Kenta Sato</name><affiliation><mods:affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kaji, Ryuji" sort="Kaji, Ryuji" uniqKey="Kaji R" first="Ryuji" last="Kaji">Ryuji Kaji</name><affiliation><mods:affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</mods:affiliation></affiliation></author><author><name sortKey="Matsumoto, Sadayuki" sort="Matsumoto, Sadayuki" uniqKey="Matsumoto S" first="Sadayuki" last="Matsumoto">Sadayuki Matsumoto</name><affiliation><mods:affiliation>Department of Neurology, Kitano Hospital and Neurological Center, Osaka, Japan</mods:affiliation></affiliation></author><author><name sortKey="Goto, Satoshi" sort="Goto, Satoshi" uniqKey="Goto S" first="Satoshi" last="Goto">Satoshi Goto</name><affiliation><mods:affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:82D7E5D647067812CD396FB00B3790D3EAA69E24</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1002/mds.21385</idno><idno type="url">https://api.istex.fr/document/82D7E5D647067812CD396FB00B3790D3EAA69E24/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003092</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title><author><name sortKey="Sato, Kenta" sort="Sato, Kenta" uniqKey="Sato K" first="Kenta" last="Sato">Kenta Sato</name><affiliation><mods:affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</mods:affiliation></affiliation></author><author><name sortKey="Kaji, Ryuji" sort="Kaji, Ryuji" uniqKey="Kaji R" first="Ryuji" last="Kaji">Ryuji Kaji</name><affiliation><mods:affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</mods:affiliation></affiliation></author><author><name sortKey="Matsumoto, Sadayuki" sort="Matsumoto, Sadayuki" uniqKey="Matsumoto S" first="Sadayuki" last="Matsumoto">Sadayuki Matsumoto</name><affiliation><mods:affiliation>Department of Neurology, Kitano Hospital and Neurological Center, Osaka, Japan</mods:affiliation></affiliation></author><author><name sortKey="Goto, Satoshi" sort="Goto, Satoshi" uniqKey="Goto S" first="Satoshi" last="Goto">Satoshi Goto</name><affiliation><mods:affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-04-15">2007-04-15</date><biblScope unit="vol">22</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="738">738</biblScope><biblScope unit="page" to="742">742</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">82D7E5D647067812CD396FB00B3790D3EAA69E24</idno><idno type="DOI">10.1002/mds.21385</idno><idno type="ArticleID">MDS21385</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>choline acetyltransferase</term><term>medium spiny neurons</term><term>multiple system atrophy</term><term>neurodegeneration</term><term>striatum</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Using antibodies to calcineurin (CaN) and choline acetyltransferase (ChAT), we performed topographical and cellular immunohistochemical analysis on the posterior putamen of autopsied patients with multiple system atrophy with predominant parkinsonism (MSA‐P). We document that in these patients, medium spiny neurons positive for CaN were severely depleted in the dorsolateral portion of the posterior putamen where ChAT‐positive neurons are normally distributed. Our findings indicate that in patients with MSA‐P, striatal neurons manifest a cell type‐specific vulnerability to neurodegeneration. © 2007 Movement Disorder Society</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Kenta Sato MD</name><affiliations><json:string>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</json:string></affiliations></json:item><json:item><name>Ryuji Kaji MD, PhD</name><affiliations><json:string>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</json:string></affiliations></json:item><json:item><name>Sadayuki Matsumoto MD, PhD</name><affiliations><json:string>Department of Neurology, Kitano Hospital and Neurological Center, Osaka, Japan</json:string></affiliations></json:item><json:item><name>Satoshi Goto MD, PhD</name><affiliations><json:string>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>multiple system atrophy</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>striatum</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>neurodegeneration</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>choline acetyltransferase</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>medium spiny neurons</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Using antibodies to calcineurin (CaN) and choline acetyltransferase (ChAT), we performed topographical and cellular immunohistochemical analysis on the posterior putamen of autopsied patients with multiple system atrophy with predominant parkinsonism (MSA‐P). We document that in these patients, medium spiny neurons positive for CaN were severely depleted in the dorsolateral portion of the posterior putamen where ChAT‐positive neurons are normally distributed. Our findings indicate that in patients with MSA‐P, striatal neurons manifest a cell type‐specific vulnerability to neurodegeneration. © 2007 Movement Disorder Society</abstract><qualityIndicators><score>3.824</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>630</abstractCharCount><pdfWordCount>2840</pdfWordCount><pdfCharCount>18969</pdfCharCount><pdfPageCount>5</pdfPageCount><abstractWordCount>82</abstractWordCount></qualityIndicators><title>Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title><genre><json:string>Serial article</json:string></genre><host><volume>22</volume><pages><total>4</total><last>742</last><first>738</first></pages><issn><json:string>0885-3185</json:string></issn><issue>5</issue><subject><json:item><value>Brief Report</value></json:item></subject><genre></genre><language><json:string>unknown</json:string></language><title>Movement Disorders</title><doi><json:string>10.1002/(ISSN)1531-8257</json:string></doi></host><publicationDate>2007</publicationDate><copyrightDate>2007</copyrightDate><doi><json:string>10.1002/mds.21385</json:string></doi><id>82D7E5D647067812CD396FB00B3790D3EAA69E24</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/82D7E5D647067812CD396FB00B3790D3EAA69E24/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/82D7E5D647067812CD396FB00B3790D3EAA69E24/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/82D7E5D647067812CD396FB00B3790D3EAA69E24/fulltext/tei"><teiHeader type="text"><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>Wiley Subscription Services, Inc., A Wiley Company</p></availability><date>2007</date></publicationStmt><notesStmt><note>Grant on Stress Control 21st Century Center of Excellence Program (COE)</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title><author><persName><forename type="first">Kenta</forename><surname>Sato</surname><roleName type="degree">MD</roleName></persName><affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</affiliation></author><author><persName><forename type="first">Ryuji</forename><surname>Kaji</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</affiliation></author><author><persName><forename type="first">Sadayuki</forename><surname>Matsumoto</surname><roleName type="degree">MD, PhD</roleName></persName><affiliation>Department of Neurology, Kitano Hospital and Neurological Center, Osaka, Japan</affiliation></author><author><persName><forename type="first">Satoshi</forename><surname>Goto</surname><roleName type="degree">MD, PhD</roleName></persName><note type="correspondence"><p>Correspondence: Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima 770‐8503, Japan</p></note><affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</affiliation></author></analytic><monogr><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="pISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><idno type="DOI">10.1002/(ISSN)1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2007-04-15"></date><biblScope unit="vol">22</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="738">738</biblScope><biblScope unit="page" to="742">742</biblScope></imprint></monogr><idno type="istex">82D7E5D647067812CD396FB00B3790D3EAA69E24</idno><idno type="DOI">10.1002/mds.21385</idno><idno type="ArticleID">MDS21385</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2007</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Using antibodies to calcineurin (CaN) and choline acetyltransferase (ChAT), we performed topographical and cellular immunohistochemical analysis on the posterior putamen of autopsied patients with multiple system atrophy with predominant parkinsonism (MSA‐P). We document that in these patients, medium spiny neurons positive for CaN were severely depleted in the dorsolateral portion of the posterior putamen where ChAT‐positive neurons are normally distributed. Our findings indicate that in patients with MSA‐P, striatal neurons manifest a cell type‐specific vulnerability to neurodegeneration. © 2007 Movement Disorder Society</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>multiple system atrophy</term></item><item><term>striatum</term></item><item><term>neurodegeneration</term></item><item><term>choline acetyltransferase</term></item><item><term>medium spiny neurons</term></item></list></keywords></textClass><textClass><keywords scheme="Journal Subject"><list><head>Article category</head><item><term>Brief Report</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2006-10-30">Received</change><change when="2006-12-04">Registration</change><change when="2007-04-15">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/82D7E5D647067812CD396FB00B3790D3EAA69E24/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8257</doi><issn type="print">0885-3185</issn><issn type="electronic">1531-8257</issn><idGroup><id type="product" value="MDS"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title><title type="short">Mov. Disord.</title></titleGroup></publicationMeta><publicationMeta level="part" position="50"><doi origin="wiley" registered="yes">10.1002/mds.v22:5</doi><numberingGroup><numbering type="journalVolume" number="22">22</numbering><numbering type="journalIssue">5</numbering></numberingGroup><coverDate startDate="2007-04-15">15 April 2007</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="260" status="forIssue"><doi origin="wiley" registered="yes">10.1002/mds.21385</doi><idGroup><id type="unit" value="MDS21385"></id></idGroup><countGroup><count type="pageTotal" number="4"></count></countGroup><titleGroup><title type="articleCategory">Brief Report</title><title type="tocHeading1">Brief Reports</title></titleGroup><copyright ownership="thirdParty">Copyright © 2007 Movement Disorder Society</copyright><eventGroup><event type="manuscriptReceived" date="2006-10-30"></event><event type="manuscriptRevised" date="2006-10-30"></event><event type="manuscriptAccepted" date="2006-12-04"></event><event type="firstOnline" date="2007-01-31"></event><event type="publishedOnlineFinalForm" date="2007-04-25"></event><event type="publishedOnlineAcceptedOrEarlyUnpaginated" date="2007-01-31"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.4.7 mode:FullText source:FullText result:FullText" date="2011-02-24"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event></eventGroup><numberingGroup><numbering type="pageFirst">738</numbering><numbering type="pageLast">742</numbering></numberingGroup><correspondenceTo>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima 770‐8503, Japan</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:MDS.MDS21385.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="1"></count><count type="tableTotal" number="0"></count><count type="referenceTotal" number="21"></count><count type="wordTotal" number="2254"></count></countGroup><titleGroup><title type="main" xml:lang="en">Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title><title type="short" xml:lang="en">Neuronal Loss in the Putamen of Patients with MSA</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Kenta</givenNames><familyName>Sato</familyName><degrees>MD</degrees></personName></creator><creator xml:id="au2" creatorRole="author" affiliationRef="#af1"><personName><givenNames>Ryuji</givenNames><familyName>Kaji</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au3" creatorRole="author" affiliationRef="#af2"><personName><givenNames>Sadayuki</givenNames><familyName>Matsumoto</familyName><degrees>MD, PhD</degrees></personName></creator><creator xml:id="au4" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Satoshi</givenNames><familyName>Goto</familyName><degrees>MD, PhD</degrees></personName><contactDetails><email normalForm="sgoto@clin.med.tokushima-u.ac.jp">sgoto@clin.med.tokushima‐u.ac.jp</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="JP" type="organization"><unparsedAffiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</unparsedAffiliation></affiliation><affiliation xml:id="af2" countryCode="JP" type="organization"><unparsedAffiliation>Department of Neurology, Kitano Hospital and Neurological Center, Osaka, Japan</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en" type="author"><keyword xml:id="kwd1">multiple system atrophy</keyword><keyword xml:id="kwd2">striatum</keyword><keyword xml:id="kwd3">neurodegeneration</keyword><keyword xml:id="kwd4">choline acetyltransferase</keyword><keyword xml:id="kwd5">medium spiny neurons</keyword></keywordGroup><fundingInfo><fundingAgency>Grant on Stress Control 21st Century Center of Excellence Program (COE)</fundingAgency></fundingInfo><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>Using antibodies to calcineurin (CaN) and choline acetyltransferase (ChAT), we performed topographical and cellular immunohistochemical analysis on the posterior putamen of autopsied patients with multiple system atrophy with predominant parkinsonism (MSA‐P). We document that in these patients, medium spiny neurons positive for CaN were severely depleted in the dorsolateral portion of the posterior putamen where ChAT‐positive neurons are normally distributed. Our findings indicate that in patients with MSA‐P, striatal neurons manifest a cell type‐specific vulnerability to neurodegeneration. © 2007 Movement Disorder Society</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><!--Version 0.6 générée le 3-12-2015--><mods version="3.6"><titleInfo lang="en"><title>Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Neuronal Loss in the Putamen of Patients with MSA</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy</title></titleInfo><name type="personal"><namePart type="given">Kenta</namePart><namePart type="family">Sato</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Ryuji</namePart><namePart type="family">Kaji</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Sadayuki</namePart><namePart type="family">Matsumoto</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Kitano Hospital and Neurological Center, Osaka, Japan</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Satoshi</namePart><namePart type="family">Goto</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima, Japan</affiliation><description>Correspondence: Department of Clinical Neuroscience, Institute of Health Biosciences, Graduate School of Medicine, University of Tokushima, Tokushima 770‐8503, Japan</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre authority="originalCategForm">article</genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2007-04-15</dateIssued><dateCaptured encoding="w3cdtf">2006-10-30</dateCaptured><dateValid encoding="w3cdtf">2006-12-04</dateValid><copyrightDate encoding="w3cdtf">2007</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">1</extent><extent unit="references">21</extent><extent unit="words">2254</extent></physicalDescription><abstract lang="en">Using antibodies to calcineurin (CaN) and choline acetyltransferase (ChAT), we performed topographical and cellular immunohistochemical analysis on the posterior putamen of autopsied patients with multiple system atrophy with predominant parkinsonism (MSA‐P). We document that in these patients, medium spiny neurons positive for CaN were severely depleted in the dorsolateral portion of the posterior putamen where ChAT‐positive neurons are normally distributed. Our findings indicate that in patients with MSA‐P, striatal neurons manifest a cell type‐specific vulnerability to neurodegeneration. © 2007 Movement Disorder Society</abstract><note type="funding">Grant on Stress Control 21st Century Center of Excellence Program (COE)</note><subject lang="en"><genre>Keywords</genre><topic>multiple system atrophy</topic><topic>striatum</topic><topic>neurodegeneration</topic><topic>choline acetyltransferase</topic><topic>medium spiny neurons</topic></subject><relatedItem type="host"><titleInfo><title>Movement Disorders</title></titleInfo><titleInfo type="abbreviated"><title>Mov. Disord.</title></titleInfo><subject><genre>article category</genre><topic>Brief Report</topic></subject><identifier type="ISSN">0885-3185</identifier><identifier type="eISSN">1531-8257</identifier><identifier type="DOI">10.1002/(ISSN)1531-8257</identifier><identifier type="PublisherID">MDS</identifier><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>738</start><end>742</end><total>4</total></extent></part></relatedItem><identifier type="istex">82D7E5D647067812CD396FB00B3790D3EAA69E24</identifier><identifier type="DOI">10.1002/mds.21385</identifier><identifier type="ArticleID">MDS21385</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2007 Movement Disorder Society</accessCondition><recordInfo><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin><recordContentSource>WILEY</recordContentSource></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003092 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 003092 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:82D7E5D647067812CD396FB00B3790D3EAA69E24
|texte= Cell type‐specific neuronal loss in the putamen of patients with multiple system atrophy
}}
| This area was generated with Dilib version V0.6.23. |  |